Desai VG - Search Results

1

MicroRNA-34a-5p as a promising early circulating preclinical biomarker of doxorubicin-induced chronic cardiotoxicity.

Desai VG, Vijay V, Lee T, Han T, Moland CL, Phanavanh B, Herman EH, Stine K, Fuscoe JC. Desai VG, et al. J Appl Toxicol. 2022 Sep;42(9):1477-1490. doi: 10.1002/jat.4309. Epub 2022 Mar 9. J Appl Toxicol. 2022. PMID: 35199358

2

Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model.

Desai VG, Herman EH, Moland CL, Branham WS, Lewis SM, Davis KJ, George NI, Lee T, Kerr S, Fuscoe JC. Desai VG, et al. Toxicol Appl Pharmacol. 2013 Jan 1;266(1):109-21. doi: 10.1016/j.taap.2012.10.025. Epub 2012 Nov 7. Toxicol Appl Pharmacol. 2013. PMID: 23142469

3

Early biomarkers of doxorubicin-induced heart injury in a mouse model.

Desai VG, C Kwekel J, Vijay V, Moland CL, Herman EH, Lee T, Han T, Lewis SM, Davis KJ, Muskhelishvili L, Kerr S, Fuscoe JC. Desai VG, et al. Toxicol Appl Pharmacol. 2014 Dec 1;281(2):221-9. doi: 10.1016/j.taap.2014.10.006. Epub 2014 Oct 23. Toxicol Appl Pharmacol. 2014. PMID: 25448438

4

Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice.

Vijay V, Moland CL, Han T, Fuscoe JC, Lee T, Herman EH, Jenkins GR, Lewis SM, Cummings CA, Gao Y, Cao Z, Yu LR, Desai VG. Vijay V, et al. Among authors: desai vg. Toxicol Appl Pharmacol. 2016 Mar 15;295:68-84. doi: 10.1016/j.taap.2016.02.003. Epub 2016 Feb 9. Toxicol Appl Pharmacol. 2016. PMID: 26873546

5

Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice.

Schnackenberg LK, Pence L, Vijay V, Moland CL, George N, Cao Z, Yu LR, Fuscoe JC, Beger RD, Desai VG. Schnackenberg LK, et al. Among authors: desai vg. J Appl Toxicol. 2016 Nov;36(11):1486-95. doi: 10.1002/jat.3307. Epub 2016 Mar 2. J Appl Toxicol. 2016. PMID: 26934058

6

Sex-related differential susceptibility to doxorubicin-induced cardiotoxicity in B6C3F₁ mice.

Jenkins GR, Lee T, Moland CL, Vijay V, Herman EH, Lewis SM, Davis KJ, Muskhelishvili L, Kerr S, Fuscoe JC, Desai VG. Jenkins GR, et al. Among authors: desai vg. Toxicol Appl Pharmacol. 2016 Nov 1;310:159-174. doi: 10.1016/j.taap.2016.09.012. Epub 2016 Sep 17. Toxicol Appl Pharmacol. 2016. PMID: 27644598

7

Candidate early predictive plasma protein markers of doxorubicin-induced chronic cardiotoxicity in B6C3F₁ mice.

Desai VG, Lee T, Moland CL, Vijay V, Han T, Lewis SM, Herman EH, Fuscoe JC. Desai VG, et al. Toxicol Appl Pharmacol. 2019 Jan 15;363:164-173. doi: 10.1016/j.taap.2018.11.016. Epub 2018 Dec 2. Toxicol Appl Pharmacol. 2019. PMID: 30517846

8

Doxorubicin-induced delayed-onset subclinical cardiotoxicity in mice.

Desai VG, Vijay V, Han T, Moland CL, Phanavanh B, Lee T, Davis KJ, Muskhelishvili L, Stine KC, Fuscoe JC. Desai VG, et al. J Appl Toxicol. 2022 May;42(5):778-792. doi: 10.1002/jat.4256. Epub 2021 Oct 20. J Appl Toxicol. 2022. PMID: 34668590

9

Potential role of the apelin-APJ pathway in sex-related differential cardiotoxicity induced by doxorubicin in mice.

Desai VG, Azevedo-Pouly A, Vijay V, Phanavanh B, Moland CL, Han T, Revollo J, Aryal B, Rao VA, Fuscoe JC. Desai VG, et al. J Appl Toxicol. 2023 Apr;43(4):557-576. doi: 10.1002/jat.4405. Epub 2022 Oct 28. J Appl Toxicol. 2023. PMID: 36227756

10

Sex differences in kidney gene expression during the life cycle of F344 rats.

Kwekel JC, Desai VG, Moland CL, Vijay V, Fuscoe JC. Kwekel JC, et al. Among authors: desai vg. Biol Sex Differ. 2013 Jul 31;4(1):14. doi: 10.1186/2042-6410-4-14. Biol Sex Differ. 2013. PMID: 23902594 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters